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Abstract
Background: Type 2 diabetes is common, on the rise, and disproportionately affects ethnic minority groups. Telehealth
interventions may mitigate diabetes-related complications, but might under-recruit or even exclude ethnic minorities, in part
because of English language requirements. The under-representation of minority patients in trials could threaten the generalizability
of the findings, whereby the patients who might stand to benefit most from such interventions are not being included in their
evaluation.
Objective: The aims of this systematic review are twofold: (1) to assess the reporting and prevalence of ethnic minorities in
published telehealth trials for type 2 diabetes, including identifying trial features associated with successful patient recruitment;
and (2) to determine the proportion of such trials that report English language proficiency as an inclusion/exclusion criterion,
including how and why they do so.
Methods: Randomized controlled trials (RCTs) of adults with type 2 diabetes in Western, English-speaking countries that
included telehealth interventions targeting diabetes as a primary condition, and those that did not specifically recruit minority
groups will be included. Search strategies were devised for indexed and keyword terms capturing type 2 diabetes, telehealth/health
technology, and RCTs in English language publications from 2000 to July 2015 in MEDLINE, PsycINFO, EMBASE, CINAHL,
and CENTRAL. Reference lists of included studies will also be searched. Two reviewers will independently screen abstracts and
full-text articles against inclusion criteria, mediated by a third reviewer if consensus cannot be reached. Data extracted from
included studies will be checked by a second reviewer and will be summarized using narrative synthesis.
Results: This research is in progress, with findings expected by Spring 2016.
Conclusions: This review will address research reporting and recruitment practices of ethnic minorities in telehealth RCTs for
type 2 diabetes. Prevalence estimates will elucidate generalizability of existing research, with implications for researchers, health
professionals, and policy makers. Identifying trial or intervention features that appear to facilitate ethnic minority recruitment,
as well as language barriers that impede it might suggest ways to improve recruitment in future trials.
Trial Registration: PROSPERO International Prospective Register of Systematic Reviews: CRD42015024899;
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015024899 (Archived by WebCite at
http://www.webcitation.org/6fUMqbJ0f).
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Introduction
Diabetes is a common chronic condition, with global estimates
of 387 million diabetic adults worldwide in 2014 [1]. This figure
is projected to rise rapidly in the coming years [1], which will
further increase the financial burden on health care systems.
About 90% of diabetic patients have type 2 diabetes, which
typically affects those of middle age or older, although the
growing incidence of childhood obesity means that this
condition is now occurring in younger populations as well [1].
Risk of developing type 2 diabetes can be reduced by making
healthier lifestyle changes, while subsequent type 2
diabetes-related complications, such as heart disease and stroke,
can be reduced from good diabetes management [2,3].
Therefore, many behavioral interventions, including those
making use of telehealth, which is defined here as the use of
technology to support the remote delivery of health care and
promote self-management [4], have targeted this condition.
Telehealth could help health systems to cope with the increasing
pressures they face with an aging population experiencing rising
rates of chronic conditions, and also empower patients to
self-manage their care. A key benefit of telehealth is that it can
improve access to care for those who experience difficulties
utilizing traditional health care [5]. Indeed, telehealth is
attracting international interest as an alternative to traditional
face-to-face care [6]. While the effectiveness evidence of
telehealth from randomized controlled trials (RCTs) is mixed
and might vary by chronic condition, systematic reviews of
telehealth interventions for type 2 diabetes have generally shown
beneficial clinical effects, such as improved blood glucose levels
[7-9]. However, many telehealth trials conducted in Western
countries recruit mostly white patients [10-12] or may not report
the ethnicity of participants [13].
The under-recruitment of certain sociodemographic groups,
such as ethnic minority populations, to telehealth RCTs
jeopardizes the generalizability of trial findings. This issue is
particularly pressing in the case of type 2 diabetes, because the
condition is about six times more prevalent in South Asians and
up to three times more common in those of African and
Afro-Caribbean descent [14]. Across ethnic minorities, the
prevalence of type 2 diabetes is 5.7%, whereas it is 1.7% for
non-Hispanic white ethnic groups [1]. If the effectiveness and
acceptability of telehealth interventions for type 2 diabetes are
mostly being trialed among white patients, whether the same
interventions would be equally beneficial in ethnic minority
groups—those with comparatively greater health needs in this
regard—is not being adequately addressed. This has implications
when considering new service delivery deployment of such
telehealth interventions.
There is some evidence for the low levels of ethnic minority
participation in telehealth interventions for diabetes, despite the
fact that ethnicity is not widely reported. In a systematic review
of 26 studies of interactive computer-based interventions for
diabetes, only 8 of these studies reported on the inclusion of
ethnic minorities, whereby the median proportion of ethnic
minority participation was 39% of the recruited study sample
(within-study range of ethnic minority participants: 5-100%)
[15]. Further to this initial investigation, a secondary aim of a
recent review by Cotter et al [16] was to examine the degree to
which Internet interventions were tailored to diverse or
underserved diabetic populations. The ethnic mix of participants
was reported in 4 of the 9 studies included in this review,
whereby there was between 24% and 100% minority group
participants across these 4 studies. Another review published
in the same year (2014) reported that half of the 16 included
RCTs contained minority prevalence information, in which the
within-study range of ethnic minority participants was 15-100%
[9].
While these reviews provide some indication about the lack of
minority patient participation and the under-reporting of
ethnicities in telehealth research for diabetes, they are subject
to several limitations. These consist of including both RCTs
and other study designs within the review [15,16], including
studies of patients with type 1 and type 2 diabetes [9,15], and
only considering a narrow range of computer technologies, to
the exclusion of other telehealth interventions [15,16]. RCTs
are held as the “gold standard” in health research because they
reduce bias and potential confounding, but they may attract
participants who differ from those taking part in other types of
studies, due to the time commitment required for participation
and other factors [17,18]. Furthermore, since it is only type 2
diabetes that disproportionately affects ethnic minority groups,
rather than type 1 diabetes, it is more important to establish the
prevalence of ethnic minorities in studies that are restricted to
type 2 diabetic patients. In addition, excluding studies that make
use of glucose monitoring or that are telephone based means
that a large volume of telehealth research in this area was not
considered. Finally, a fundamental issue affecting prevalence
estimates of ethnic minorities in the 2 more recent reviews
[9,16]—albeit not the focus of either review—is that they
included studies that, during recruitment, specifically targeted
just one or more ethnic minority groups. This is problematic
because it overestimates and biases prevalence estimates, as
well as masks overall user acceptance in the general patient
population. To overcome these limitations, a more
comprehensive systematic review of the literature is required,
as well as exploring potential barriers and facilitators to ethnic
minority participation in telehealth trials.
One frequently cited challenge in reference to minority group
participation in RCTs relates to patients’ language proficiency
and literacy [19,20]. Among those living in the United States,
around 25 million people are unable to speak English fluently
[21], while it is estimated that almost 300,000 adults in England
and Wales from the 4 most common ethnic minority groups
speak little or no English [22]. Ensuring that patients have the
requisite language ability to understand the conditions of
research participation is essential in all research studies for
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ethical reasons (eg, obtaining informed consent). Moreover,
because a fundamental component of telehealth interventions
involves non-face-to-face communication, being able to engage
in efficient communication is integral to participating in and
benefiting from telehealth interventions. It is unclear whether
researchers are utilizing objective and systematic ways of
assessing whether patients have the necessary language skills
to participate in telehealth RCTs for diabetes, or whether such
decisions are made more subjectively. The role that language
plays in telehealth trial participant inclusion or exclusion
decisions, therefore, needs to be systematically investigated.
This is of particular significance for type 2 diabetes trials, where
minority patients who potentially stand to benefit most from
such interventions need to be proportionally represented, and
language barriers may impede their ability to do so in telehealth
trials targeting this condition. To our knowledge, no systematic
review has examined language as a potential barrier to ethnic
minority participation in telehealth trials for type 2 diabetes.
Taken together, the potential under-recruitment of ethnic
minorities and language barriers present two major issues facing
telehealth RCTs for type 2 diabetes. Both affect the
generalizability of trial findings and have wider implications
for the adoption of new telehealth services into health care
systems, as well as equitable access to health care. Therefore,
the aims of this systematic review are twofold: (1) to assess the
reporting and prevalence of ethnic minorities in published
telehealth trials for type 2 diabetes, including identifying trial
features associated with successful patient recruitment (trial
includes ≥30% ethnic minorities, in line with median prevalence
across earlier reviews [9,15,16]); and (2) to determine the
proportion of such trials that report English language proficiency
as an inclusion/exclusion criterion, including how and why they
do so. Building on the previously mentioned reviews [9,15,16],
our study will update and refine the ethnic minority prevalence
figures with more stringent criteria (ie, RCTs only, adult type
2 diabetes patients only, excluding studies with an ethnically
targeted sample) intended to minimize the effects of extraneous
variables that could bias estimates. Compared with the earlier
reviews, we will also include a broader range of telehealth
interventions that make use of any technology medium. In
addition, we will move beyond simple reporting and seek to
identify the characteristics of trials that have higher proportions
of ethnic minority participation.
Methods
This systematic review will be conducted in accordance with
the Cochrane Handbook for Systematic Reviews of Interventions
[23] and will follow the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) guidelines
[24].
Search Strategy
We will search for potentially eligible studies using MEDLINE
(via Ovid), PsycINFO (via Ovid), EMBASE (via Ovid),
CINAHL (via EBSCOhost), and the Cochrane Central Register
of Controlled Trials (CENTRAL, via Wiley Online Library)
from January 1, 2000, to July 31, 2015. Reference lists of
included studies will also be searched.
Both Medical Subject Heading (MeSH) terms and keywords
will be used in the searches to capture themes of type 2 diabetes,
telehealth/health technology, and RCTs (see Multimedia
Appendix 1 for MEDLINE example). Because of the varied
terms researchers tend to use to describe telehealth, the search
incorporates numerous plausible key terms. We also examined
key terms used in related diabetes telehealth systematic reviews
with similar inclusion and exclusion criteria to ensure
comprehensive searching [7-9,25]. We consulted a medical
subject librarian to finalize the strategy. Search filters restrict
results to English language publications, humans, and the
relevant publication dates.
Screening and Study Selection
The database searches will be performed by one reviewer (LE).
Citations and abstracts will be uploaded into EndNote X7,
de-duplicated, and screened for eligibility against the inclusion
criteria by the same reviewer (LE). A second reviewer (KB)
will concurrently and independently assess the titles and
abstracts against the inclusion criteria. Discrepancies will be
resolved through discussion and achieving consensus, or by
consulting a third reviewer (TI) if consensus cannot be reached.
Reasons for excluding abstracts will be recorded for later
reporting.
After retrieving the full text of the studies that remain after the
first stage of assessment, 2 reviewers (LE and DW) will
independently review the full text for further eligibility
assessment. Reasons for exclusion will be recorded for reporting
in the PRISMA flow diagram. As before, discrepancies will be
resolved through consensus or by consulting a third reviewer
(TI) when consensus cannot be reached. Multiple reports from
the same study will be linked for included studies.
Inclusion Criteria
The following criteria will be used to select studies for inclusion
in the review.
Study Designs
Only RCTs will be included, which could include two- or more
arm trials, pilot studies, cross-over designs, cluster RCTs, and
so on.
Participants
The review will be limited to adult patients (aged ≥ 18 years)
of either sex with type 2 diabetes in Western countries where
English is both an official and a majority language (USA,
Canada, the United Kingdom, Ireland, Australia, and New
Zealand). Only participants recruited widely from the general
patient population will be included, rather than RCTs that
specifically aim to include just one or more ethnic groups. This
is because we are interested in assessing the prevalence of ethnic
minorities in typical telehealth RCTs, in which the focus is
simply on achieving the target sample size. Studies that include
a homogeneous ethnic minority sample will artificially inflate
the prevalence results. However, trials recruiting from other
specific contexts (eg, urban/rural; economically
deprived/low-income/medically underserved groups) will be
permitted. We acknowledge that there may be a relationship
between ethnicity and these other sociodemographic
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characteristics, but studies that include such samples are unlikely
to result in completely homogeneous ethnic samples. In addition,
telehealth is meant to address barriers to accessing traditional
health care, and, therefore, recruitment within these contexts is
a direct test of a typically cited advantage of telehealth [26].
Interventions
Telehealth interventions of any duration, using any technology
medium specifically designed to treat or improve type 2 diabetes
as the primary condition, will be included. By this, we mean
interventions targeting or monitoring blood glucose levels,
diabetes education/knowledge, medication adherence, and
diabetes self-care behaviors (eg, foot checking and
exercise/diet/weight interventions), whereas mental health
interventions and treatment of other secondary diabetes-related
complications (eg, foot ulcers, cardiovascular health) will not
be included. As outlined in the “Introduction” section and
illustrated in the search strategy (see Multimedia Appendix 1),
we take a broad definition of telehealth, which includes
telemedicine, telemonitoring, teleconsultations, medical
informatics, eHealth and mHealth (electronic or mobile health),
or other forms of remote health care delivery, treatment, and
support. However, the intervention must be described by the
authors as telehealth or the majority of the intervention must
be delivered electronically, rather than in-person.
Comparators
We will include studies employing any comparison group within
an RCT, such as usual care, wait-list control group, or
head-to-head trials.
Outcomes
Studies will not be selected on the basis of any reported
outcomes. The primary outcomes of the review will include
1. Proportion of RCTs that report on the ethnic/racial
composition of trial participants.
2. Overall prevalence of ethnic minorities reported in telehealth
trials for patients with type 2 diabetes (between-study median
and range).
3. Features of studies that include a higher proportion of ethnic
minorities (≥30% of the sample), such as country, recruitment
setting (primary care, community, secondary care), telehealth
medium (telephone, video, email, etc), resource availability
(translation/interpretation), targeting of low-income recipients,
tailoring of intervention (to individual needs, cultural group,
etc).
4. Proportion of telehealth trials for type 2 diabetes that report
English language proficiency (oral/written) or literacy as
inclusion/exclusion criteria.
5. Way in which English language proficiency/literacy is
operationalized by authors reporting this as inclusion/exclusion
criteria.
6. Reason(s) that patients are excluded on language grounds
(eg, ethical considerations, ability to participate in intervention,
lack of translation/interpretation resources).
Setting and Timing
There are no restrictions on the study setting or length of
intervention or follow-up.
Report Characteristics
The review will include RCTs published in English in
peer-reviewed journals between 2000 and 2015. The rationale
for this 15-year publication restriction is that we are interested
in capturing the current state of telehealth RCTs for type 2
diabetes. Health technology has evolved rapidly within this
period and telehealth trials have also proliferated in recent years,
and so this time frame should provide an up-to-date and
sufficient summary of ethnic minority participation and language
recruitment barriers in trials.
Exclusion Criteria
Because of the greater risk of bias and potential confounds,
study designs other than RCTs (eg, observational studies,
surveys), including nonrandomized controlled studies, will be
excluded. The following additional exclusions apply: (1)
systematic or other literature reviews, letters,
commentaries/editorials, study protocols, conference abstracts,
or presentations; (2) secondary subgroup analyses of RCTs or
RCT-generated data modeling studies; (3) RCTs not published
in peer-reviewed journals, such as dissertations and case reports;
(4) targeted ethnic minority trials (could be a single ethnic
minority sample, or a dedicated comparison between one or
more ethnic groups), although the number of such studies and
recruited patients of various ethnic backgrounds that would
otherwise have met our eligibility criteria will be recorded; (5)
mixed (type 1 and type 2) diabetes samples, type 1 diabetes,
gestational (pregnancy) diabetes, or diabetes insipidus; (6)
studies involving adolescents or children; (7) telehealth
interventions directed at and solely experienced by health
professionals, even if the study measures the effect of such
interventions on type 2 diabetic patients; and (8) telehealth
interventions directed solely at diabetes-related complications,
such as diabetic retinopathy, hypertension, diabetes distress.
Interventions addressing both primary and secondary diabetes
issues will, however, be included.
Data Collection
Data extraction forms will be developed for the current review
using existing guidelines [23]. The form will contain information
about the (1) study details (eg, country, recruitment setting,
design, inclusion and exclusion criteria), (2) participant
demographics (eg, sample size, age, sex, ethnic mix, baseline
diabetes severity), and (3) intervention characteristics (eg,
description, duration, frequency, telehealth medium). A
complete list of all variables is available through PROSPERO
[27]. Outcome data will be abstracted by one reviewer (DH)
into Excel, and independently checked by a second reviewer
(DW). Disagreements will be resolved by a third reviewer (TI).
The Cochrane risk of bias tool [28] will be used to assess
selection, performance, detection, attrition, reporting, and
“other” sources of bias. Accordingly, a judgment of “high,”
“low,” or “unclear” bias along with supporting justification will
be provided and recorded using Review Manager (RevMan,
version 5.3; Copenhagen: The Nordic Cochrane Centre, The
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Cochrane Collaboration, 2014). Two reviewers (LE and DH)
will assess all studies, which will be checked by another
reviewer (DW). As before, disagreements will be resolved
through discussion or by consulting a third reviewer (TI).
We anticipate a high degree of missing or unreported ethnicity
data in the studies, as well as few details regarding English
language inclusion or exclusion criteria. It is, however, beyond
the scope of this review to supplement recruitment-related
information provided in refereed journal articles by consulting
the gray literature or contacting authors for missing information.
While we acknowledge this limitation, this is consistent with
the overall goal of the review to systematically document what
is and is not reported in peer-reviewed trial publications.
Data Synthesis
Proportions of ethnic minorities included across studies (overall,
and by specific ethnic group), as well as frequencies of trials
reporting English language as inclusion/exclusion criteria, will
be presented for individual included studies and aggregated
across included studies.
The results will be presented in a narrative synthesis using the
synthesis framework developed by Popay and colleagues [29].
The framework sets out the following 4 key elements to
narrative synthesis: (1) developing a theory of how the
intervention works, why, and for whom; (2) developing a
preliminary synthesis of findings of included studies; (3)
exploring relationships in the data; and (4) assessing the
robustness of the synthesis. In terms of the first element, which
focuses on constructing a theory around the intervention’s
effectiveness, we will re-frame this according to our final
research question concerning what features of telehealth trials
for type 2 diabetes tend to successfully recruit a sizeable
proportion of ethnic groups. We are interested in the kinds of
recruitment techniques, studies, or interventions that appear to
result in more ethnically balanced telehealth trial samples (≥30%
ethnic minority participants). These insights could inform
current recruitment practice for targeting ethnically diverse
patients in telehealth studies, taking language support and other
factors into account. Thus, we will seek to develop a theory
around this facet. We will use an inductive approach, in which
a theory will be formulated based on themes or patterns that
emerge from the data.
As outlined in Popay and colleagues [29], several tools and
techniques will be used in processing the data around each of
the elements, which could include textual descriptions,
groupings and clusters (eg, by telehealth intervention medium,
country), tabulation, thematic analysis, concept mapping, and
reflecting critically on the synthesis process. In line with the
guidance, we will undertake these processes iteratively and will
discuss the emerging results with the research team throughout.
An additional, retrospective subgroup analysis (added after
PROSPERO registration) will be carried out on trials that
specifically targeted ethnic minority groups as part of their
recruitment strategy. The aim of this analysis will be to identify
trial features or strategies that were employed that potentially
resulted in heightened recruitment of these targeted groups. All
such trials will have otherwise met the inclusion criteria for the
full systematic review, except that recruitment was aimed at
one or more ethnic minority groups.
Results
This systematic review is currently underway, with results
anticipated by Spring 2016.
Discussion
This systematic review will provide up-to-date prevalence
estimates of research-reporting practices and participation rates
of ethnic minorities in telehealth trials for type 2 diabetes that
make use of a broad range of technologies. The inclusion of
ethnic minorities in type 2 diabetes telehealth research is
methodologically important to maximize the external validity
of findings, in addition to extending the potential benefits of
telehealth type 2 diabetes research to a wider cross section of
patients. These factors, coupled with the rapid rise of telehealth
interventions, make the need to assess language as a potential
recruitment barrier for minority participation, as well as
highlighting facilitators to recruitment, all the more pressing.
Moreover, determining which kinds of trials or interventions
tend to attract a higher proportion of ethnic minorities has
significance for a variety of stakeholders in the health care
system. This could inform trial recruitment strategies, thereby
enhancing the ethnic mix within trials, increasing the external
validity of findings, while also ensuring a broad spectrum of
diabetic patients evaluate and potentially benefit from such
telehealth interventions. From a more macro level, greater
insight into the characteristics of trials that successfully recruit
a heterogeneous population is synchronous with the overarching
goal of promoting greater social inclusiveness and more
equitable access to health care.
Ethnic minority participation in type 2 diabetes telehealth RCTs
will impact health systems when considering commissioning
new services for patients, in which effectiveness across
ethnically diverse groups and, in particular, among ethnic
minorities that are disproportionately affected by type 2 diabetes
must be demonstrated. While the 3 previously cited reviews
[9,15,16] marked an important first step in tabulating the
prevalence of ethnic minorities included in telehealth
interventions for diabetes, they also highlighted how few studies
(31-50%) actually reported on the ethnic mix of the study
sample. If this is still the case in this up-to-date comprehensive
review, despite the widespread adoption of best reporting
practices for studies, such as the Consolidated Standards of
Reporting Trials 2010 (CONSORT) statement [30], then this
suggests the need for further attention in research reporting.
These guidelines state that baseline characteristics of trial
participants should be reported, which is predicated by the fact
that this information is gathered as part of data collection. We
contend that this is especially pressing in trials of chronic
conditions in which there is known to be variation in prevalence
by sociodemographic variables, and that it is precisely these
variables that constitute which key baseline characteristics ought
to be reported.
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